Table of Contents
<< Previous Issue | Apr 2018 (Vol: 2018, Issue: 4) | Next Issue >> |
- Section: Licensing
-
AstraZeneca Licenses Preclinical NASH Candidate from Partner Ionis
- Section: Mergers & Acquisitions
-
GSK Acquires Novartis’ Stake in Consumer Healthcare Joint Venture for US$13 B
-
Lundbeck Bolsters its Parkinson’s Pipeline by Acquiring Prexton Therapeutics
-
Novartis Spends US$8.7 B on Gene Therapy Biotech AveXis
-
Alexion to Acquire Rare Disease Specialist Wilson Therapeutics